体外膜氧合期间的抗菌药物管理:挑战与新视角
ECMO回路可隔离和再分布抗菌药物,增加剂量不足和毒性风险;预防性抗生素获益有限且促进耐药;方案驱动的预防、治疗药物监测和及时降阶梯等管理干预可行,跨专业管理项目或可减少抗菌药物消耗和成本而不影响结局。
要点
- ECMO回路隔离和再分布抗菌药物,增加剂量不足与毒性风险。
- 预防性抗生素获益有限且促进耐药,使用仍存争议。
- 方案驱动预防、治疗药物监测和及时降阶梯等管理干预可行。
核心结论
- 危重症和ECMO改变抗菌药物暴露,需抗菌药物管理方法以防止耐药。
- 跨专业管理项目结合合理抗菌药物使用与严格非药物感染预防,或可减少抗菌药物消耗和耐药而不影响结局,但证据缺口仍存。
主要发现
- ECMO回路隔离和再分布抗菌药物,增加剂量不足和毒性风险。
- 危重症患者常伴代谢紊乱和肾脏替代治疗等临床挑战,可能使抗生素治疗复杂化。
- 预防性抗生素使用仍存争议,证据提示预防感染获益有限而促进抗菌药物耐药。
- 新兴研究强调方案驱动预防、治疗药物监测和及时降阶梯广谱药物等管理干预的可行性(疗效尚未证实)。
- 跨专业抗菌药物管理项目可能减少抗菌药物消耗和成本而不影响患者结局。
临床怎么用
- 在ECMO患者中考虑方案驱动的预防、治疗药物监测和及时降阶梯广谱抗菌药物。
- 实施跨专业抗菌药物管理项目以优化使用并减少消耗和成本。
- 将严格无菌技术和预防集束化措施等非药物感染控制作为抗菌药物策略的必要补充。
局限性
- 关于ECMO患者最佳给药方案和管理框架仍存在显著知识缺口。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Extracorporeal membrane oxygenation (ECMO) has emerged as a crucial modality in managing severe cardiac and respiratory failure; however, nosocomial infections and complex antimicrobial prescribing challenges may accompany its use. OBJECTIVES: This review examines the unique interplay between infection risk, ECMO-related alterations in antimicrobial pharmacokinetics/pharmacodynamics, and the important role of antimicrobial stewardship. SOURCES: We performed a comprehensive literature search in PubMed, Embase, Cochrane Library, and Web of Science electronic libraries from database inception to December 2025, to identify studies relevant to antimicrobial stewardship during ECMO. CONTENT: The ECMO circuit sequesters and redistributes antimicrobials, increasing the risk of both underdosing and toxicity. In addition, critically ill patients frequently face clinical challenges that may complicate antibiotic therapy, such as metabolic derangements and renal replacement therapy. The use of prophylactic antibiotics remains a topic of controversy, with evidence suggesting only limited benefit in preventing infections while promoting antimicrobial resistance. In this respect, emerging studies highlight the feasibility, if not yet efficacy, of stewardship interventions such as protocol-driven prophylaxis, therapeutic drug monitoring, and timely de-escalation of broad-spectrum agents. Interprofessional antimicrobial stewardship programs may reduce antimicrobial consumption and costs without compromising patient outcomes. Nonpharmacologic infection control measures, including strict aseptic techniques and adherence to preventive bundles, are essential complements to antimicrobial strategies. Despite the growing evidence base, significant knowledge gaps persist regarding optimal dosing regimens and stewardship frameworks tailored to ECMO patients. IMPLICATIONS: Critical illness and ECMO alter antimicrobial exposure and antibiotic use in such complex clinical scenarios necessitates stewardship approaches to prevent antimicrobial resistance. Interprofessional stewardship programs combining judicious antimicrobial use with robust nonpharmacologic infection prevention may reduce antimicrobial consumption and resistance without compromising outcomes, despite ongoing evidence gaps.
引用
- Abdulaziz S, Alhajri HS, So M, et al. Antimicrobial stewardship during extracorporeal membrane oxygenation: challenges and new perspectives. Clin Microbiol Infect. 2026. PMID: 41759951. doi:10.1016/j.cmi.2026.02.021
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。